A critical advance in cancer investigation is emerging with the use of VHH fragments to reactivate damaged p53. This crucial tumor suppressor protein is frequently disabled in many kinds of tumors, leading uncontrolled https://bookmarkyourpage.com/story7494325/mini-antibodies-revive-p53-a-promising-pathway-for-malignant-management